March 15, 2011

Cardiovascular Disease Medications After Renal Transplantation: Results From the Patient Outcomes in Renal Transplantation Study

.   .   

Renal transplantation reduces the risk of cardiovascular events compared to dialysis, but these patients remain a high-risk group. This large international registry study shows that use of common cardioprotective agents such as antiplatelets agents, statins, beta-blockers, ACE-inhibitors and ARBs is lower than would be expected, although their use has increased over time. Whether increased use of these medications can reduce death from cardiovascular disease post-transplant is unknown.

Related Articles:

Renal Transplantation, Vascular Disease/Calcification

Comments are closed.